SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Collagen Corp.
CGEN 1.780+7.9%Oct 31 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: OldAIMGuy who wrote (63)12/23/1997 9:12:00 AM
From: Jonathan Rothschild  Read Replies (2) of 72
 
Stock is under greater accumulation than it has been for 4 years. Big short-term news is the surprisingly strong launch of softform implant. 600 surgeons trained already and it's a high ticket procedure with big gross margin. Biggest suprise will be Euro approval of cohesion spray next Fall. I wouldn't be surprised if a heavyweight like Baxter of Boston Scientific would take them out. Split up IMHO is a non-event, but will get some institutional interest, especially if they decide to raise a little money. Contigen is reramping and breast implant shell problems are reportedly solved which should slow the burn of that division. Baby boomers keeping demand for Zyderm/plast. Hyaluform ramp going very well in Europe.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext